BCL2A1 and lymphoma: However, transgenic BCL2A1 mice do not develop lymphomas [26], [27], suggesting that either BCL2A1 overexpression is not sufficient for tumorigenesis or BCL2A1 functions differ between mice and humans, as is the case of BCL2A1 cellular distribution.